Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Recent advances with liposomes as pharmaceutical carriers10.1038/nrd1632 ↗
2. Folate-PEG coated cationic modified chitosan–cholesterol liposomes for tumor-targeted drug delivery10.1016/j.biomaterials.2010.01.089 ↗
3. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery10.1016/j.biomaterials.2012.09.027 ↗
4. Doxil®-the first FDA-approved nano-drug: lessons learned10.1016/j.jconrel.2012.03.020 ↗
5. The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia10.1080/10428190500052438 ↗
6. Role of tumor vascular architecture in drug delivery10.1016/j.addr.2011.04.002 ↗
7. Intracellular trafficking mechanism, from intracellular uptake to extracellular efflux, for phospholipid/cholesterol liposomes10.1016/j.biomaterials.2012.07.030 ↗
8. Endocytic mechanisms for targeted drug delivery10.1016/j.addr.2007.06.008 ↗
9. High performance mRNA transfection through carbonate apatite–cationic liposome conjugates10.1016/j.biomaterials.2009.02.050 ↗
10. An intracellular lamellar–nonlamellar phase transition rationalizes the superior performance of some cationic lipid transfection agents10.1073/pnas.0603085103 ↗
11. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter10.1016/j.biomaterials.2011.10.082 ↗
12. Endosomal escape and transfection efficiency of PEGylated cationic liposome–DNA complexes prepared with an acid-labile PEG-lipid10.1016/j.biomaterials.2012.03.038 ↗
13. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells10.1016/j.jconrel.2006.12.019 ↗
14. Gene transfer efficiency of high primary amine content, hydrophobic, alkyl-oligoamine derivatives of polyethylenimine10.1016/j.biomaterials.2009.04.036 ↗
15. Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model10.1016/j.biomaterials.2009.03.040 ↗
16. Synthesis and characterization of four-arm poly(ethylene glycol)-based gene delivery vehicles coupled to integrin and DNA-binding peptides10.1021/mp700072n ↗
17. Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution10.1016/S0968-0896(99)00209-6 ↗
18. “SMART” drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers10.1021/bc060080h ↗
19. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery10.1016/j.biomaterials.2009.07.020 ↗
20. Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo10.1016/j.jconrel.2009.10.023 ↗
21. Multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery10.1002/adma.201201498 ↗
22. Endocytosis of murine norovirus 1 into murine macrophages is dependent on dynamin II and cholesterol10.1128/JVI.00331-10 ↗
23. Subcellular trafficking and transfection efficacy of polyethylenimine-polyethylene glycol polyplex nanoparticles with a ligand to melanocortin receptor-110.1016/j.jconrel.2012.08.027 ↗
24. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling10.1083/jcb.200908086 ↗
25. Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery10.1016/j.nano.2006.11.005 ↗
26. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo10.1016/j.biomaterials.2010.11.010 ↗
27. Formulations of biodegradable nanogel carriers with 5′-triphosphates of nucleoside analogs that display a reduced cytotoxicity and enhanced drug activity10.1016/j.jconrel.2007.04.007 ↗
28. Reduction-triggered delivery using nucleoside-lipid based carriers possessing a cleavable PEG coating10.1016/j.jconrel.2011.02.008 ↗
29. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting10.1016/j.jconrel.2010.03.016 ↗
30. Targeted charge-reversal nanoparticles for nuclear drug delivery10.1002/anie.200605254 ↗
31. Charge-conversional polyionic complex micelles-efficient nanocarriers for protein delivery into cytoplasm10.1002/anie.200900064 ↗
32. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles10.1021/bm101482r ↗
33. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity10.1016/j.jconrel.2011.12.002 ↗
34. Pyridylhydrazone-based PEGylation for pH-reversible lipopolyplex shielding10.1016/j.biomaterials.2010.09.032 ↗
35. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression10.1074/jbc.M503202200 ↗
36. Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery10.1038/mt.2011.99 ↗
37. Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers10.1111/j.1476-5381.2009.00288.x ↗
38. Super pH-sensitive multifunctional polymeric micelle10.1021/nl0479987 ↗
39. Serum tolerance and endosomal escape capacity of histidine-modified pDNA-loaded complexes based on polyamidoamine dendrimer derivatives10.1016/j.biomaterials.2012.07.032 ↗
40. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol–distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells10.1016/j.biomaterials.2011.04.029 ↗
41. Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells10.1016/j.biomaterials.2011.09.055 ↗
42. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo10.1016/j.jconrel.2012.01.009 ↗
43. Apoptosis in cancer10.1093/carcin/21.3.485 ↗
44. Mitochondrially targeted anti-cancer agents10.1016/j.mito.2010.06.004 ↗
45. Targeting mitochondria as a therapeutic target in cancer10.1002/jcp.22788 ↗
46. Targeting apoptosis pathways in cancer therapy
47. mTOR-targeted therapy of cancer with rapamycin derivatives10.1093/annonc/mdi113 ↗
48. FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction10.1073/pnas.261702698 ↗
49. Direct control of mitochondrial function by mTOR10.1073/pnas.0912074106 ↗